March 31 (Reuters) - Hyloris Pharmaceuticals SA HYL.BR :
* HYLORIS LAUNCHES EQUITY OFFERING BY MEANS OF A PRIVATE
PLACEMENT
VIA AN ACCELERATED BOOKBUILD OFFERING
* LAUNCH OF AN EQUITY OFFERING TO RAISE AN AMOUNT OF
APPROXIMATELY
EUR 15 MILLION BY MEANS OF A PRIVATE PLACEMENT VIA AN
ACCELERATED BOOKBUILD OFFERING
* OFFERING WILL NOT BE OPEN TO PUBLIC
* HYLORIS CURRENTLY ENVISAGES USING NET PROCEEDS OF OFFERING
TO:PRIMARILY FUND DEVELOPMENT OF ADDITIONAL NEW PRODUCT
CANDIDATES
* BOARD OF DIRECTORS OF COMPANY HAS DECIDED TO CANCEL
PREFERENTIAL
SUBSCRIPTION RIGHTS OF EXISTING SHAREHOLDERS IN CONTEXT OF
OFFERING
* POSSIBILITY TO INCREASE SIZE OF OFFERING
* EXISTING SHAREHOLDERS NOSHAQ SA AND S.R.I.W. SA ARE
SUPPORTIVE
OF OFFERING AND HAVE INDICATED AN INTENTION TO SUBMIT AN ORDER.
* EXISTING SHAREHOLDERS NOSHAQ SA AND S.R.I.W. SA ARE
SUPPORTIVE
OF OFFERING AND HAVE INDICATED AN INTENTION TO SUBMIT AN ORDER.
* ENVISAGSE TO USE NET PROCEEDS TO ACCELERATE IN-HOUSE
RESEARCH
AND DEVELOPMENT ACTIVITIES, INCLUDING REPURPOSING AND ANALYTICAL
EXPERTISE.
* TRADING IN SHARES IS EXPECTED TO RESUME FOLLOWING
PUBLICATION OF
RESULTS OF OFFERING.
* IN RELATION TO OFFERING, COMPANY HAS AGREED WITH
UNDERWRITERS TO
A MARKET CUSTOMARY 180-DAYS STANDSTILL PERIOD ON FUTURE SHARE
ISSUANCES, WAIVABLE BY UNDERWRITERS AND SUBJECT TO CUSTOMARY
EXCEPTIONS.
Source text for Eikon: ID:nGNE6j1X1Y
Further company coverage: HYL.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))